Serologic indicators in infection by hepatitis virus type B
Hernández, N.; Rodríguez, J.R.; Gorbea, H.F.; Colón Quintana, M.; Christenson, B.; Ramírez-Ronda, C.H.
Boletin de la Asociacion Medica de Puerto Rico 76(6): 245-248
1984
ISSN/ISBN: 0004-4849 PMID: 6590058 Document Number: 701387
Document emailed within 1 workday
Related Documents
Caspari, G.; Gerlich, W.H. 2007: The Serologic Markers of Hepatitis B Virus Infection - Proper Selection and Standardized Interpretation Clinical Laboratory 53(5-6): 335-343Wong, S.; Mehta, A.E.; Faiman, C.; Berard, L.; Ibbott, T.; Minuk, G.Y. 1996: Absence of serologic evidence for hepatitis C virus infection in patients with Hashimoto's thyroiditis Hepato-Gastroenterology 43(8): 420-421
Del Olmo, J.A.; Añón, C.; Llovet, F.; Serra, M.A.; Wassel, A.; Rodrigo, J.M. 1995: Comparative study of the prevalence of hepatitis B virus infection and human immunodeficiency virus type 1 infection in the prison population between 1985 and 1992 Gastroenterologia y Hepatologia 18(8): 405-409
Steele, A.D.; Bos, P.; Joubert, J.J.; Bafort, J.M.; Lecatsas, G.; Aspinall, S. 1995: Serologic markers for hepatitis B virus and hepatitis a virus in Bushmen in West Caprivi, Namibia East African Medical Journal 72(1): 30-32
Boroń, P.; Bobrowska, E.; Borzuchowska, A.; Kaczmarska, A.; Kamińska, H.; Prokopowicz, D.; Szpakowicz, T.; Sidun, Z. 1987: Occurrence of antigens and specific antibodies against hepatitis B virus infection in relation to other immunoserological indicators in alcohol-dependent persons Przeglad Epidemiologiczny 41(3): 311-318
Mikhaylov, M.I.; Mamedov, M.K.; Dadasheva, A.E. 2015: Viral indicators of the increased epidemiological hazard of subjects from high risk groups of hepatitis C virus parenteral infection Voprosy Virusologii 60(2): 38-40
Eisenburg, J. 1995: Differential diagnosis of hepatitis A, B, C, D and E. Clinical, biochemical and virus serologic criteria. 4: Hepatitis D serology Fortschritte der Medizin 113(3): 35-36
Eisenburg, J. 1995: Differential diagnosis of hepatitis A, B, C, D and E. Clinical, biochemical and virus serologic criteria. 5: Hepatitis C serology Fortschritte der Medizin 113(4): 41-42
Sungkanuparph, S.; Vibhagool, A.; Manosuthi, W.; Kiertiburanakul, S.; Atamasirikul, K.; Aumkhyan, A.; Thakkinstian, A. 2004: Prevalence of hepatitis B virus and hepatitis C virus co-infection with human immunodeficiency virus in Thai patients: a tertiary-care-based study Journal of the Medical Association of Thailand 87(11): 1349-1354
Adoga, M.P.; Banwat, E.B.; Forbi, J.C.; Nimzing, L.; Pam, C.R.; Gyar, S.D.; Agabi, Y.A.; Agwale, S.M. 2009: Human immunonodeficiency virus, hepatitis B virus and hepatitis C virus: sero-prevalence, co-infection and risk factors among prison inmates in Nasarawa State, Nigeria Journal of Infection in Developing Countries 3(7): 539-547
Ruzibakiev, R.; Kato, H.; Ueda, R.; Yuldasheva, N.; Hegay, T.; Avazova, D.; Kurbanov, F.; Zalalieva, M.; Tuichiev, L.; Achundjanov, B.; Mizokami, M. 2001: Risk factors and seroprevalence of hepatitis B virus, hepatitis C virus, and human immunodeficiency virus infection in uzbekistan Intervirology 44(6): 327-332
Horsmans, Y.; Tennstedt, D.; Cornu, C.; Geubel, A.P. 1998: Failure of cyclosporin therapy in type Ii mixed cryoglobulinemia associated with hepatitis C virus infection Clinical and Experimental Rheumatology 16(4): 514-515
Reuter, G.áb.; Szucs, G.ör. 2004: Is endemic hepatitis e infection present in developed countries?--Accumulating information about the hepatitis e virus and hepatitis e infection Orvosi Hetilap 145(51): 2555-2561
Cremer, K.; Wohlenberg, C.; Notkins, A.L.; Mackett, M.; Moss, B. 1985: Vaccinia virus recombinant that expresses the herpes simplex virus type 1 glycoprotein d gene protects mice against lethal challenge by herpes simplex virus type 1 or herpes simplex type 2 and the establishment of a latent ganglionic infection by herpes simplex virus type 1 Lerner, R A , R M Chanock And F Brown (Ed ) Vaccines 85: Molecular And Chemical Basis Of Resistance to Parasitic, Bacterial, And Viral Diseases; Meeting, 1983 Xxi+407p Cold Spring Harbor Laboratory: Cold Spring Harbor, N Y , Usa Illus Paper 169-174
Cremer, K.; Wohlenberg, C.; Notkins, A.L.; Mackett, M.; Moss, B. 1985: Vaccinia virus recombinant that expresses the herpes simplex virus type 1 glycoprotein d gene protects mice against lethal challenge by herpes simplex virus type 1 or herpes simplex type 2 and the establishment of a latent ganglionic infection by herpes simplex virus type 1 Lerner, R A , R M Chanock And F Brown (Ed ) Vaccines 85: Molecular And Chemical Basis Of Resistance to Parasitic, Bacterial, And Viral Diseases; Meeting, 1983 Xxi+407p Cold Spring Harbor Laboratory: Cold Spring Harbor, N Y , Usa Illus Paper 169-174
Sardà Jansà, N.; Santacatalina Ubiedo, L. 1994: Hepatitis b virus serologic markers Atencion Primaria 13(3): 144-145
Guardia, J.; Esteban, R. 1985: Serologic markers of hepatitis B virus Medicina Clinica 84(15): 612-613
Son, H.-C.; Yoon, M.-S.; Kim, Y.-J.; Kim, I.-H.; Kim, Y.-S. 2002: Type-specific antibody for hepatitis C virus detected by use of NS-4 peptide and hepatitis C virus genome in Korea Rinsho Byori. Japanese Journal of Clinical Pathology 50(5): 533-540
Beebe, J.L. 1978: Serologic testing for viral hepatitis, type B Journal of the American Medical Women's Association 33(1): 41; 47
Toyoda, H.; Fukuda, Y.; Hayakawa, T. 1997: Hepatitis GB virus C infection in Japanese hemophiliacs with persistent hepatitis C virus infection Nihon Rinsho. Japanese Journal of Clinical Medicine 55(3): 554-558